Frank Carter, a 67-year-old cancer survivor, celebrates his recovery by canoeing 2,000 miles down the Missouri River with his dog, Amos, following groundbreaking immunotherapy treatment.
Frank Carter, a 67-year-old resident of Orange County, Florida, has completed an extraordinary 2,000-mile canoe journey down the Missouri River, accompanied by his loyal dog, Amos. This adventure comes four years after Carter underwent CAR T-cell therapy that successfully treated his lymphoma.
Over the course of 64 days, Carter navigated the longest river in the United States in a cedar-strip canoe he crafted by hand. The expedition commenced in Montana and concluded near St. Louis, Missouri. Along the way, the duo camped on riverbanks and faced various challenges, including severe storms, high winds, and hail, as reported by FOX 13 News and the Moffitt Cancer Center.
Before his cancer diagnosis, Carter was no stranger to long-distance adventures. In 2019, he hiked the Appalachian Trail for five months and completed an eight-week cross-country bicycle ride from San Diego to New Smyrna Beach, Florida, in 2020. However, his physical endurance was put to the test in 2021 after a routine 5K race left him feeling unusually fatigued.
“I was wiped out. I just wasn’t recovering,” Carter recalled in an interview with FOX 13 News. “I went to my doctor, had blood tests. Long story short, in two weeks I was getting chemo.”
Doctors diagnosed Carter with mantle cell lymphoma, a rare form of blood cancer that originates in white blood cells known as lymphocytes. He underwent 15 rounds of chemotherapy in Orlando, which significantly reduced the cancer, but follow-up exams revealed lingering traces of the disease.
Seeking further treatment, Carter turned to the Moffitt Cancer Center in Tampa, where he underwent chimeric antigen receptor (CAR) T-cell therapy. This innovative treatment involves extracting the patient’s own immune cells, genetically modifying them in a laboratory to recognize cancer cells, and reintroducing them into the body.
“We take those T-cells and genetically engineer them by putting something called a CAR into them,” explained Dr. Michael Jain, an oncologist at Moffitt Cancer Center, in an interview with FOX 13 News. “Now these T-cells can see the tumor and get rid of it, where before the tumor was able to hide from it.”
Remarkably, Carter has remained cancer-free for four years following the single infusion of CAR T-cell therapy. Throughout his recovery journey, he found unwavering support in Amos, the dog he adopted just before starting chemotherapy.
“After my cancer diagnosis, I told myself I was going to beat this, and I really wanted a dog during the process,” Carter shared with Moffitt’s Endeavor publication. “I got Amos right before my first treatment.”
Carter’s remarkable journey not only highlights the advancements in cancer treatment but also underscores the importance of companionship and resilience in the face of adversity. His story serves as an inspiration to many who are battling similar challenges.
For more information on innovative cancer treatments, visit the Moffitt Cancer Center website.
According to Moffitt Cancer Center.